CAESARS ENTMT INC. DL-,01CAESARS ENTMT INC. DL-,01CAESARS ENTMT INC. DL-,01

CAESARS ENTMT INC. DL-,01

No trades
See on Supercharts

Price target

50.490.00 0.00%
The 17 analysts offering 1 year price forecasts for 2ER have a max estimate of — and a min estimate of —.

Analyst rating

Based on 19 analysts giving stock ratings to 2ER in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

2ER EPS for the last quarter is −0.68 EUR despite the estimation of −0.07 EUR. In the next quarter EPS is expected to reach 0.16 EUR. Track more of CAESARS ENTMT INC. DL-,01 financials and stay on top of what is up with the company.
In the next quarter CAESARS ENTMT INC. DL-,01 revenue is expected to reach ‪2.68 B‬ EUR. Check out CAESARS ENTMT INC. DL-,01 revenue and earnings and make informed decisions.
According to analysts, 2ER price target is 50.49 EUR with a max estimate of 64.46 EUR and a min estimate of 39.60 EUR. Check if this forecast comes true in a year, meanwhile watch CAESARS ENTMT INC. DL-,01 stock price chart and keep track of the current situation with 2ER news and stock market news.
We've gathered opinions of 19 analysts rating 2ER stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.